Bioptik Technology (ROCO:4161) PEG Ratio: N/A (As of Jul. 12, 2026)


ROCO:4161 Bioptik Technology Inc ROCO:4161
68 GF Score
Price NT$23.00
GF Value NT$27.79
Valuation Modestly Undervalued
! 2 Warning Signs
View Full Analysis

What is Bioptik Technology PEG Ratio?

PE Ratio without NRI / 5-Year EBITDA Growth Rate*

PEG Ratio is defined as the PE Ratio without NRI divided by the growth ratio. The growth rate we use is the 5-Year EBITDA growth rate. As of today, Bioptik Technology's PE Ratio without NRI is 18.91. Bioptik Technology's 5-Year EBITDA growth rate is 0.00%. Therefore, Bioptik Technology's PEG Ratio for today is N/A.

* The 5-Year EBITDA Growth Rate is the 5-year average EBITDA per share growth rate. While the denominator is a percentage, we use the whole number as opposed to the decimal form for the calculation. For example, 5% would be shown as 5 as opposed to 0.05. If it's smaller than or equal to 0, then the PEG Ratio is not calculated.


The historical rank and industry rank for Bioptik Technology's PEG Ratio or its related term are showing as below:



ROCO:4161's PEG Ratio is not ranked *
in the Medical Devices & Instruments industry.
Industry Median: 1.93
* Ranked among companies with meaningful PEG Ratio only.

Peter Lynch thinks a company with a P/E ratio equal to its growth rate is fairly valued.


Bioptik Technology  (ROCO:4161) PEG Ratio Explanation

To compare stocks with different growth rates, Peter Lynch invented a ratio called PEG Ratio. PEG Ratio is defined as the P/E ratio divided by the growth ratio. He thinks a company with a P/E ratio equal to its growth rate is fairly valued. Still he said he would rather buy a company growing 20% a year with a P/E of 20, instead of a company growing 10% a year with a P/E of 10.


Bioptik Technology PEG Ratio Related Terms


Bioptik Technology PEG Ratio Historical Data

* Premium members only.

The historical data trend for Bioptik Technology's PEG Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Bioptik Technology PEG Ratio Chart

Bioptik Technology Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
PEG Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

Bioptik Technology Quarterly Data
Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25
PEG Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

ROCO:4161 vs ABT, SYK, MDT: PEG Ratio Comparison

For the Medical Devices subindustry, Bioptik Technology's PEG Ratio, along with its competitors' market caps and PEG Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Bioptik Technology PEG Ratio vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Bioptik Technology's PEG Ratio distribution charts can be found below:

* The bar in red indicates where Bioptik Technology's PEG Ratio falls into.


ROCO:4161
68GF Score
Bioptik Technology Inc ROCO:4161
PEG Ratio is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Bioptik Technology PEG Ratio Calculation

PEG Ratio is defined as the PE Ratio without NRI divided by the growth ratio. The ratio we use is the 5-Year EBITDA growth rate.

Bioptik Technology's PEG Ratio for today is calculated as

PEG Ratio=PE Ratio without NRI/5-Year EBITDA Growth Rate*
=18.914473684211/0.00
=N/A

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Note: The 5-Year EBITDA Growth Rate is the 5-year average EBITDA per share growth rate. While the denominator is a percentage, we use the whole number as opposed to the decimal form for the calculation. For example, 5% would be shown as 5 as opposed to 0.05. If it's smaller than or equal to 0, then the PEG Ratio is not calculated.

Is Bioptik Technology (ROCO:4161) Overvalued in 2026?

Based on GuruFocus' analysis, Bioptik Technology stock appears to be undervalued. The current stock price of NT$23.00 is trading 17.2% below its estimated GF Value™ of NT$27.79. GuruFocus considers Bioptik Technology to be Modestly Undervalued.

Key valuation signals for ROCO:4161:

  • PEG Ratio: N/A
  • GF Value™: NT$27.79 vs. price of NT$23.00 (17.2% below fair value)
  • GF Score™: 68/100 with 2 warning signs

No single metric tells the full story. See the ROCO:4161 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Bioptik Technology Business Description

Address No.188, Zhonghua South Road, Miaoli County, Zhunan, TWN, 35057
Bioptik Technology Inc is a Taiwan-based company engaged in the research, development, production, and sale of medical devices and reagents. The company is also focused on developing skin care products and aims to engage in developing bioenergy, Astaxanthin, and Cellulose Bioethanol. It is involved in the business areas of Home care medical devices, Skincare- Its own brand, Dietary supplement OEM and ODM, Skincare- OEM and ODM, and Biodiesel. In the Home care business area, the company provides Easy Touch blood glucose monitoring, and blood cholesterol and uric acid monitoring systems, as well as its strips.
68GF Score

Get the complete analysis for ROCO:4161

PEG Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

NT$23.00
Price
NT$27.79
GF Value